Home > Healthcare & Medical Devices > Pet Diabetes Care Devices Market

Pet Diabetes Care Devices Market Size By Device Type (Glucose Monitoring Devices, Insulin Delivery Devices {Insulin Delivery Pen, Insulin Syringes}) By Animal Type (Cats, Dogs, Horses), By End-use (Veterinary Clinics, Home Care Settings, Veterinary Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI4444
  • Published Date: Feb 2022
  • Report Format: PDF

Industry Overview

Pet Diabetes Care Devices Market size was valued at over USD 2 billion in 2021 and is anticipated to witness 6.9% CAGR from 2022 to 2028 owing to the increasing number of pets suffering from diabetes coupled with increasing pet care expenditure.
 

Pet Diabetes Care Devices Market

Get more details on this report - Request Free Sample PDF
 

Diabetes in pets is caused due to absolute, relevant insulin deficiency or an inadequate biological response to it. Insulin secreted by the pancreas controls the glucose levels in the blood. The ingested food is broken down into glucose among other components which is then carried by insulin to the cells and is utilized in the form of energy.
 

Lack of insulin production leads to the limited amount of glucose transportation to the cells. This results in inappropriate cell functioning and the tissue starves for energy. This metabolic starvation triggers the liver to break down additional sugar stored in the muscles, liver and fat cells. The rising prevalence of diabetes among pets is a major concern for pet owners across the globe as an increasing number of pets are diagnosed with diabetes.
 

Diabetes is a chronic condition that commonly develops in older pets and sometimes in the younger pets as well. Unlike humans, certain pets are genetically prone to develop diabetes, however being overweight increases the risk of developing diabetes in pets. As pet diabetes cannot be cured, increasing efforts from pet owners and key stakeholders in the pet diabetes care devices market are targeted towards its optimum management. Effective diabetic care and management does not affect pet’s quality of life. Pets with diabetes usually require lifelong treatment with good fitness regimen, special diet and particularly in dogs, daily insulin injections.
 

Increasing adoption of pets have fostered the pet diabetes care market statistics

Increasing adoption of pets for companionship and safety-related factors has significantly increased the spending on pet care. Majority of the pet owners are noted to consider their pets as family members and look after them with utmost care that contributes to increased pet care spending.
 

The increasing disposable income of pet owners further propels the pet ownership rate, leading to an increased pet healthcare spending in tandem. For instance, according to the American Pets Products Association, in 2021, 90.5 million families own a pet in the U.S. Hence, increasing pet care expenditure and their well-being such as regular health check-ups and growing advancement in treatment solutions are major factors propelling the pet diabetes care devices market share over the forecast period.
 

Limited awareness surrounding proper management of pet diabetes may restrict the market growth

Diabetes in pets is a complex disease and cannot be cured with the medications, but it can be detected early and managed efficiently with the help of veterinarian, proper treatment, diet, and exercise ensuring a health life. However, regular medication in pets leads to various side effects. Additionally, diabetic pets are observed to be more prone to other infections. Increased sugar level may lead to cataract that can potentially reduce a pet’s eyesight, sense of smelling and hearing ability. Further, increased blood sugar levels also cause the risk of urinary tract infections.
 

Some of the other problems that may occur include hypokalemia, high blood pressure, stomach ulcers, lumps and bumps, skin irritation, lethargy, anaphylaxis, liver, or kidney damage, among others. Limited awareness among the general population regarding pet diabetes is noted to be one of the prominent factors for the pet diabetes care devices market growth.
 

The emergence of COVID – 19 pandemic has significantly increased public healthcare concern impacting the global economy. As the cases were noted to rise, several local and national regulatory bodies were noted to impose restrictions on the movement of goods and people.
 

With the advent of COVID – 19 pandemic, global supply chain hindrances were noted to impact the overall sales of the pet diabetes care devices. However, this was primarily offset by the increased demand from pet owners in an attempt to stock essential pet care products, including diabetes devices such as pet diabetes care devices. Further, as several key players operating in the pet diabetes care devices market were identified as essential services providers, the manufacturers were allowed to operate as usual, and the market witnessed only minor implications.
 

Pet adoption witnessed a spike throughout 2020 however, as the situation normalises, an increasing concern is observed surrounding the rising rate of abandoned pets. Hence, as the pandemic crisis unfolds, the short-term mixed effects of pandemic have left the investors unsure whether the surge in overall pet care market will remain the same or change over the years.
 

As a result, due to travel restrictions and closure of veterinary clinics, the market witnessed slightly negative impact. However, reducing COVID-19 cases and rising pet care expenditure are expected to complement the pet diabetes care devices market over the coming years.
 

Increasing pet adoption coupled with growing technological advancements will fuel the segmental expansion

Global Pet Diabetes Care Devices Market Share By Device Type

Get more details on this report - Request Free Sample PDF
 

By device type, the market is segmented into glucose monitoring and insulin delivery pet diabetes care devices. The insulin delivery pet diabetes care devices segment is further sub segmented into insulin delivery pen and insulin delivery syringes. The glucose monitoring pet diabetes care devices segment is anticipated to witness a significant 4.9% market growth over the forecast period. Increase in the number of pets diagnosed with diabetes is predominantly contributing to the increasing adoption of advanced pet diabetes care devices such as glucose monitoring pet diabetes care devices, primarily in the developed countries.
 

The rising pet adoption coupled with the increasing pet care expenditures are some of the key factors compelling the market players to intensify R&D activities and developing advanced technology for pet diabetes care and management. Key players such as Merck and TaiDoc, among others, have introduced novel solutions such as insulin delivery pens and glucose monitoring pet diabetes care devices specifically designed for pets.
 

Dogs segment is estimated to maintain the dominance throughout the projected time frame

By animal type, the pet diabetes care devices are bifurcated into dogs, cats and horses. Dogs segment is forecast to account for over USD 1.8 billion by the end of 2028 due to the rising obesity among dogs. According to the Veterinary Centers of America Animal Hospitals, among the dogs aged between 5-11 years, over 40-45% weigh above average in North America. Further, certain breeds of dogs such as Miniature Schnauzers, Pugs, Bichon Frises, among others, are highly susceptible to developing diabetes mellitus. Thus, rising obesity rates are one of the prime causes of pet diabetes, indicating a positive growth trajectory in the pet diabetes care devices market.
 

Increasing adoption of advanced diagnostic tools for diagnosis in veterinary hospitals will significantly boost the market statistics

The pet diabetes care devices market by end-use segment is classified into veterinary clinics, home care settings and veterinary hospitals. Veterinary hospitals segment accounted for a significant market share of over 42.6% in 2021 owing to the increasing expenditure on veterinary care and hospitals equipped with advanced diagnostic tools. With the rising demand for upgraded veterinary healthcare infrastructure, hospitals witness a higher patient footfall.
 

Hence, increasing number of market players are focusing on targeting several sales channels towards veterinary hospitals to enhance their presence in the overall market for pet diabetes care devices. In developing economies owing to cost efficiency the growing preference for government hospitals is expected to fuel the segmental growth. Moreover, in developed economies the growing trend of pet insurance will further propel the pet diabetes care devices market growth in foreseeable future.
 

Growing number of pet adoption and ownership in the North America region will boost the market forecasts

Global Pet Diabetes Care Devices Market Size By Region

Get more details on this report - Request Free Sample PDF
 

North America pet diabetes care devices market accounted for USD 888.5 million in 2021 and is anticipated to show lucrative market growth of 6.2% through 2028 owing to an increase in the number of pet adoptions in the region. For instance, as per the National Pet Owners Survey conducted by the American Pet Products Association (APPA), 68% of U.S. households, or about 85 million families own a pet. Therefore, dogs and cats are found to be the most common pets in U.S. households.
 

Thus, increasing trend of pet adoption and rising concern among their owners regarding their health are prominent factors fuelling the industry growth. Furthermore, presence of key market players in the region coupled with growing prevalence of diabetes is expected to spur the regional market growth for pet diabetes care devices.
 

Market players are focusing on R&D of novel pet diabetes care devices to strengthen its market position

Few of the prominent players operating in the pet diabetes care devices industry are Zoetis, Ulticare, Merck, Bayer, Boehringer Ingelheim Vetmedica Inc., TaiDoc and Allison medical. These market players are executing various strategies such as acquisitions and collaborations, new product launch in order to generate high revenue share in animal diabetes care devices market.
 

Some of the recent industry developments:

  • In August 2019, Merck Animal Health, Zoetis, and Purina continued the Diabetes Pet Care Alliance program. Since 2014, the alliance aids pet owners in screening, diagnosis of thousands of pets, educating pet owners and providing complimentary products for better diabetes management. This alliance helps the companies to gain customer loyalty as well as enhance their product penetration.
     

Pet diabetes care devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028, for the following segments:

By Devices Type

  • Glucose monitoring devices
  • Insulin delivery devices
    • Insulin delivery pen
    • Insulin syringes

By Animal Type

  • Cats
  • Dogs
  • Horses

By End-use

  • Veterinary clinics
  • Home care settings
  • Veterinary hospitals

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market size for pet diabetes care devices exceeded USD 2 billion in 2021 and is expected to record a CAGR of 6.9% between 2022 and 2028 driven by an increase in the number of pets suffering from diabetes.

Glucose monitoring pet diabetes care devices market size is poised to grow at a rate of 4.9% up to 2028 considering the rising adoption of advanced devices, primarily in developed countries.

North American market for pet diabetes care devices is slated to expand at a rate of 6.2% by 2028 impelled by an upsurge in pet adoptions in the region.

Major pet diabetes care device companies include TaiDoc, Ulticare, Allison Medical, Boehringer Ingelheim Vetmedica Inc., Merck, Zoetis, Bayer, and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 246
  • Countries covered: 19
  • Pages: 140

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount